Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.62 USD | -0.34% | -0.68% | -9.36% |
Financials (USD)
Sales 2024 * | 200M | Sales 2025 * | 261M | Capitalization | 1.2B |
---|---|---|---|---|---|
Net income 2024 * | -195M | Net income 2025 * | -163M | EV / Sales 2024 * | 4.44 x |
Net cash position 2024 * | 313M | Net cash position 2025 * | 217M | EV / Sales 2025 * | 3.77 x |
P/E ratio 2024 * |
-6.78
x | P/E ratio 2025 * |
-8.41
x | Employees | 355 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.51% |
Latest transcript on Deciphera Pharmaceuticals, Inc.
1 day | -0.34% | ||
1 week | -0.68% | ||
Current month | -7.06% | ||
1 month | -4.01% | ||
3 months | +3.47% | ||
6 months | +40.71% | ||
Current year | -9.36% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 53 | 18-05-16 |
Tucker Kelly
DFI | Director of Finance/CFO | 53 | 15-01-31 |
Kevin Brodbeck
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patricia Allen
BRD | Director/Board Member | 62 | 16-08-31 |
Edward Benz
BRD | Director/Board Member | 78 | 19-06-30 |
Ron Squarer
CHM | Chairman | 57 | 19-12-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 2 M€ | -.--% | ||
0.04% | 237 M€ | +1.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 14.62 | -0.34% | 322,798 |
24-04-23 | 14.67 | +0.62% | 426,396 |
24-04-22 | 14.58 | -0.61% | 611,443 |
24-04-19 | 14.67 | +3.09% | 394,297 |
24-04-18 | 14.23 | -3.33% | 764,426 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.36% | 1.21B | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- DCPH Stock